Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir | Zendy

Bernard Masquelier | Zendy; Kevin Assoumou | Zendy; Diane Descamps | Zendy; Laurence Bocket | Zendy; Jacqueline Cottalorda | Zendy; Annick Ruffault | Zendy; AnneGeneviève Marcelin | Zendy; Laurence MorandJoubert | Zendy; Catherine Tamalet | Zendy; C. Charpentier | Zendy; Gilles Peytavin | Zendy; Zeina Antoun | Zendy; Françoise BrunVézinet | Zendy; Dominique Costagliola | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir

Author(s) -

Bernard Masquelier,

Kevin Assoumou,

Diane Descamps,

Laurence Bocket,

Jacqueline Cottalorda,

Annick Ruffault,

AnneGeneviève Marcelin,

Laurence MorandJoubert,

Catherine Tamalet,

C. Charpentier,

Gilles Peytavin,

Zeina Antoun,

Françoise BrunVézinet,

Dominique Costagliola

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn127

Subject(s) - ritonavir , medicine , protease inhibitor (pharmacology) , genotype , mutation , resistance mutation , virology , viral load , gastroenterology , human immunodeficiency virus (hiv) , biology , antiretroviral therapy , genetics , rna , reverse transcriptase , gene

We developed clinically relevant genotypic scores for resistance to fosamprenavir/ritonavir in HIV-1 protease inhibitor (PI)-experienced patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research